Dave & Buster’s Entertainment, Inc. (PLAY) is scheduled to report fourth-quarter fiscal 2024 results on April 07, 2025, after market close. In the last reported quarter, the company posted an earnings miss of 7.1%.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.PLAY’s Q4 ExpectationsThe Zacks Consensus Estimate for the fiscal fourth-quarter bottom line is pegged at 66 cents per share, indicating a decline of 35.9% year over year.For revenues, the consensus mark is pegged at $548 mil ...

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or ...

Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or ...

Dave Inc. (NASDAQ: DAVE ) is a financial technology company that offers banking services, personal finance tools, cash advance features, and many other solutions. The company is largely known for being a leading neobank and operating on a digital-first platform (mobile app) with noAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses ...

One stock that might be an intriguing choice for investors right now is Dave Inc. (DAVE) . This is because this security in the Technology Services space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Technology Se ...

DALLAS, March 18, 2025 (GLOBE NEWSWIRE) -- Dave & Buster's Entertainment, Inc., (NASDAQ:PLAY), ("Dave & Buster's" or "the Company"), an owner and operator of entertainment and dining venues, today announced that it will report financial results for its fourth quarter and fiscal year ended February 4, 2025 after the market closes on Monday, April 7, 2025. Management will host a conference call to discuss these results on Monday, April 7, 2025, at 4:00 p.m. Central Time (5:00 p.m. Eastern Time). A live and ar ...

Core Insights - NeuroOne Medical Technologies Corporation is focused on improving surgical care for patients with neurological disorders, particularly epilepsy, through innovative technology [1][5] - The company’s OneRF® Ablation System is the first FDA 510(k)-cleared device that can record brain activity and perform RF ablation simultaneously, representing a significant advancement in epilepsy treatment [3][4] Industry Overview - Over 50 million people globally are affected by epilepsy, with nearly one-third experiencing seizures that do not respond to medication, highlighting a substantial need for alternative treatment options [2] - Radiofrequency (RF) ablation therapy is emerging as a promising solution for patients who do not respond to traditional medication [2] Company Technology - The OneRF® system consists of three main components: an electrode for stimulation and monitoring, a temperature probe, and a radio frequency heat generator [3] - The system aims to improve patient outcomes by combining real-time monitoring with targeted ablation in a single procedure, potentially reducing the need for multiple invasive surgeries [4] Future Applications - NeuroOne is also exploring the potential of its technology for applications beyond epilepsy, including pain management and other neurological disorders such as Parkinson's disease and chronic pain [5]

Core Insights - NeuroOne Medical Technologies Corporation is focused on improving surgical care for patients with neurological disorders, particularly epilepsy, through innovative technology [1][5] - The OneRF® Ablation System is a significant advancement in epilepsy treatment, being the first FDA 510(k)-cleared device that can record brain activity and perform RF ablation simultaneously [3][4] Industry Overview - Over 50 million people globally are affected by epilepsy, with nearly one-third experiencing medication-resistant seizures, highlighting the need for alternative treatment options like RF ablation therapy [2] - The medical technology sector is increasingly focusing on minimally invasive solutions for neurological disorders, which may lead to improved patient outcomes and reduced procedural costs [5] Company Developments - The OneRF® system includes an electrode for brain activity monitoring, a temperature probe, and a radio frequency heat generator, enhancing the efficiency and precision of epilepsy treatments [3][4] - NeuroOne is also exploring the potential applications of its technology in pain management and other neurological conditions, indicating a broader market strategy [5]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Dave Inc. due to allegations of misleading business information [1] Group 1: Legal Actions and Allegations - The Justice Department and the Federal Trade Commission (FTC) announced a civil enforcement action against Dave Inc. and its CEO Jason Wilk for alleged violations of the FTC Act and the Restore Online Shoppers' Confidence Act [3] - The lawsuit claims that Dave misled consumers through deceptive advertising of cash advances, hidden fees, misrepresentation of customer tips usage, and recurring monthly fees without a simple cancellation mechanism [3] Group 2: Market Reaction - Following the announcement of the lawsuit, Dave's share price fell by 8% on December 31, 2024 [4] Group 3: Class Action Information - Investors who purchased Dave securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - Interested investors can join the class action by visiting the provided link or contacting the Rosen Law Firm directly [2] Group 4: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and recognition in the field [5] - The firm was ranked No. 1 for securities class action settlements in 2017 and has recovered hundreds of millions of dollars for investors over the years [5]

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Dave Inc. due to allegations of misleading business information issued by the company [1] Group 1: Legal Actions and Allegations - The Justice Department and the Federal Trade Commission announced a civil enforcement action against Dave Inc. and its CEO Jason Wilk for alleged violations of the FTC Act and the Restore Online Shoppers' Confidence Act [3] - The lawsuit claims that Dave misled consumers through deceptive advertising of cash advances, hidden fees, misrepresentation of customer tips usage, and recurring monthly fees without an easy cancellation mechanism [3] Group 2: Market Reaction - Following the announcement of the lawsuit, Dave's share price fell by 8% on December 31, 2024 [4] Group 3: Class Action Information - Investors who purchased Dave securities may be entitled to compensation through a class action lawsuit, with no out-of-pocket fees due to a contingency fee arrangement [2] - Interested investors can join the class action by submitting a form or contacting the Rosen Law Firm directly [2] Group 4: Rosen Law Firm's Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements and being ranked highly in the field since 2013 [5] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering investor losses [5]